PT738150E - Antagonistas biciclicos de fibrinogenio - Google Patents

Antagonistas biciclicos de fibrinogenio

Info

Publication number: PT738150E
Authority: PT; Portugal
Prior art keywords: fibrinogenic; antagonists; bicycle; fibrinogenic bicycle; bicycle antagonists
Prior art date: 1994-01-07

Application number

PT95908006T

Other languages

English (en)

Inventor

William Francis Huffman

James Francis Callahan

William Edward Bondinell

Richard Mcculloch Keenan

Thomas Wen-Fu Ku

Kenneth Allen Newlander

James Martin Samanen

Irene Nijole Uzinskas

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-01-07

Filing date

1995-01-09

Publication date

2003-08-29

1995-01-09 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2003-08-29 Publication of PT738150E publication Critical patent/PT738150E/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Diabetes (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Hydrogenated Pyridines (AREA)

PT95908006T 1994-01-07 1995-01-09 Antagonistas biciclicos de fibrinogenio PT738150E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US17901194A	1994-01-07	1994-01-07

Publications (1)

Publication Number	Publication Date
PT738150E true PT738150E (pt)	2003-08-29

Family

ID=22654859

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT95908006T PT738150E (pt)	1994-01-07	1995-01-09	Antagonistas biciclicos de fibrinogenio

Country Status (27)

Country	Link
US (1)	US6117866A (pt)
EP (1)	EP0738150B1 (pt)
JP (1)	JPH09508620A (pt)
KR (1)	KR100388772B1 (pt)
CN (1)	CN1117569C (pt)
AP (1)	AP542A (pt)
AT (1)	ATE238993T1 (pt)
AU (1)	AU699186B2 (pt)
BG (2)	BG62844B1 (pt)
BR (1)	BR9506499A (pt)
CZ (1)	CZ292323B6 (pt)
DE (1)	DE69530571T2 (pt)
DK (1)	DK0738150T3 (pt)
ES (1)	ES2197914T3 (pt)
HK (1)	HK1014668A1 (pt)
HU (1)	HUT76282A (pt)
IL (1)	IL112243A (pt)
MA (1)	MA23420A1 (pt)
NO (1)	NO962859L (pt)
NZ (1)	NZ279394A (pt)
OA (1)	OA10368A (pt)
PT (1)	PT738150E (pt)
SG (1)	SG64884A1 (pt)
SK (1)	SK86996A3 (pt)
TW (1)	TW420682B (pt)
WO (1)	WO1995018619A1 (pt)
ZA (1)	ZA9545B (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA955391B (en) *	1994-06-29	1996-02-09	Smithkline Beecham Corp	Vitronectin receptor antagonists
US6458784B1 (en) *	1994-06-29	2002-10-01	Smithkline Beecham Corporation	Vitronectin receptor antagonists
US6008214A (en) *	1994-08-22	1999-12-28	Smithkline Beecham Corporation	Bicyclic compounds
DE19516483A1 (de) *	1995-05-05	1996-11-07	Merck Patent Gmbh	Adhäsionsrezeptor-Antagonisten
ZA9610853B (en)	1995-12-29	1998-04-06	Smithkline Beecham Corp	Processes and intermediates for preparing pharmaceuticals.
ES2205254T3 (es) *	1996-09-03	2004-05-01	Smithkline Beecham Corporation	Producto farmaceutico cristalino.
JP2001507231A (ja) *	1996-12-27	2001-06-05	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	ベンゾジアゼピン−酢酸エステルのリパーゼによる酵素的分割
IL136602A0 (en) *	1997-12-09	2001-06-14	Ihara Chemical Ind Co	Process for preparing toluene derivatives
US6548663B1 (en)	1998-03-31	2003-04-15	Bristol-Myers Squibb Pharma Company	Benzodiazepine vitronectin receptor antagonist pharmaceuticals
TR200101757T2 (tr)	1998-12-18	2001-12-21	Dupont Pharmaceuticais Company	Vitronektin reseptör antagonisti farmasötikler
US6569402B1 (en)	1998-12-18	2003-05-27	Bristol-Myers Squibb Pharma Company	Vitronectin receptor antagonist pharmaceuticals
GB9908662D0 (en) *	1999-04-15	1999-06-09	Smithkline Beecham Plc	Novel process for preparing benzodiazepines
CO5180550A1 (es) *	1999-04-19	2002-07-30	Smithkline Beecham Corp	Inhibidores de fab i
AR024158A1 (es)	1999-06-01	2002-09-04	Smithkline Beecham Corp	Compuestos antibacterianos
US6730684B1 (en)	1999-10-08	2004-05-04	Affinium Pharmaceuticals, Inc.	Fab I inhibitors
US6762201B1 (en)	1999-10-08	2004-07-13	Affinium Pharmaceuticals, Inc.	Fab I inhibitors
EP1226138B1 (en)	1999-10-08	2004-12-29	Affinium Pharmaceuticals, Inc.	Fab i inhibitors
SE9904377D0 (sv) *	1999-12-01	1999-12-01	Astra Pharma Prod	Pharmaceutical combinations
US6964974B2 (en)	2000-09-08	2005-11-15	Hoffmann-La Roche Inc.	2,3-oxidosqualene-lanosterol cyclase inhibitors
US7049310B2 (en)	2001-04-06	2006-05-23	Affinium Pharmaceuticals, Inc.	Fab I inhibitors
US20030051728A1 (en)	2001-06-05	2003-03-20	Lloyd Peter M.	Method and device for delivering a physiologically active compound
US20070122353A1 (en)	2001-05-24	2007-05-31	Hale Ron L	Drug condensation aerosols and kits
US7458374B2 (en)	2002-05-13	2008-12-02	Alexza Pharmaceuticals, Inc.	Method and apparatus for vaporizing a compound
US7645442B2 (en)	2001-05-24	2010-01-12	Alexza Pharmaceuticals, Inc.	Rapid-heating drug delivery article and method of use
WO2003059251A2 (en)	2001-10-22	2003-07-24	The Scripps Research Institute	Antibody targeting compounds
US7691847B2 (en) *	2002-10-17	2010-04-06	The Trustees Of The University Of Pennsylvania	Method of treating neurological diseases and disorders
US20040105818A1 (en)	2002-11-26	2004-06-03	Alexza Molecular Delivery Corporation	Diuretic aerosols and methods of making and using them
US7913688B2 (en)	2002-11-27	2011-03-29	Alexza Pharmaceuticals, Inc.	Inhalation device for producing a drug aerosol
EP1625336B9 (en)	2003-05-21	2012-03-21	Alexza Pharmaceuticals, Inc.	Use of a layer of solid fuel, method for producing such a layer and associated heating unit
GB0321256D0 (en) *	2003-09-11	2003-10-08	Generics Uk Ltd	Novel crystalline compounds
US7759387B2 (en)	2003-10-08	2010-07-20	Piramal Life Sciences Limited	Fibrinogen receptor antagonists and their use
US7540286B2 (en)	2004-06-03	2009-06-02	Alexza Pharmaceuticals, Inc.	Multiple dose condensation aerosol devices and methods of forming condensation aerosols
WO2007048127A2 (en) *	2005-10-20	2007-04-26	The Scripps Research Institute	Fc labeling for immunostaining and immunotargeting
EP2687533B1 (en)	2006-07-20	2017-07-19	Debiopharm International SA	Acrylamide derivatives as FAB I inhibitors
US8263613B2 (en)	2007-02-16	2012-09-11	Affinium Pharmaceuticals, Inc.	Salts, prodrugs and polymorphs of fab I inhibitors
EP2121088B1 (en)	2007-03-09	2016-07-13	Alexza Pharmaceuticals, Inc.	Heating unit for use in a drug delivery device
US8518927B2 (en)	2009-02-10	2013-08-27	The Scripps Research Institute	Chemically programmed vaccination
EP2861608B8 (en)	2012-06-19	2019-06-19	Debiopharm International SA	Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
MY189221A (en)	2016-02-26	2022-01-31	Debiopharm Int Sa	Medicament for treatment of diabetic foot infections
WO2019152873A1 (en)	2018-02-02	2019-08-08	Alexza Pharmaceuticals, Inc.	Electrical condensation aerosol device
WO2019210308A1 (en) *	2018-04-27	2019-10-31	Arrowhead Pharmaceuticals, Inc.	Integrin targeting ligands and uses thereof

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1592552A (en) *	1976-12-10	1981-07-08	Inst Nat Sante Rech Med	Pseudopeptides used as medicaments
LU77316A1 (pt) *	1977-05-11	1979-01-19
CA1145333A (en) *	1980-02-08	1983-04-26	Quirico Branca	Benzodiazepine derivatives
CA1163266A (en) *	1980-07-31	1984-03-06	Albert E. Fischli	Benzodiazepine derivatives
CA1157855A (en) *	1980-07-31	1983-11-29	Albert E. Fischli	Benzodiazepine derivatives
NL8005133A (nl) *	1980-09-12	1982-04-01	Duphar Int Res	Fenylpiperazinederivaten met antiagressieve werking.
US4410520A (en) *	1981-11-09	1983-10-18	Ciba-Geigy Corporation	3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
NZ204130A (en) *	1982-05-12	1986-03-14	Hoffmann La Roche	Bicyclic heterocyclic compounds and pharmaceutical compositions
US5059688A (en) *	1982-06-14	1991-10-22	Hoechst-Roussel Pharmaceuticals Inc.	1-aryloxy-2,3,4,5-tetrahydro-3-benzazepine preparation
DE3418271A1 (de) *	1984-05-17	1985-11-21	Dr. Karl Thomae Gmbh, 7950 Biberach	Neue benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US4820834A (en) *	1984-06-26	1989-04-11	Merck & Co., Inc.	Benzodiazepine analogs
EP0204349A3 (de) *	1985-06-01	1990-01-03	Dr. Karl Thomae GmbH	Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
ES2052595T3 (es) *	1986-12-15	1994-07-16	Inst Nat Sante Rech Med	Nuevos derivados peptidicos y su aplicacion en especial en terapeutica.
DE3702755A1 (de) *	1987-01-30	1988-08-11	Hoechst Ag	3,5-di-tert.-butyl-4-hydroxybenzoesaeureamid, verschiedene von dessen derivaten, verfahren zur herstellung dieser verbindungen, die sie enthaltenden arzneimittel und ihre verwendung
ATE140926T1 (de) *	1987-12-10	1996-08-15	Jolla Cancer Res Found	Verfahren zur herstellung von conformationnell stabilisierten zelladhäsionspeptiden
DK107688D0 (da) *	1988-03-01	1988-03-01	Novo Industri As	Carbaminsyreestere af substituerede 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepiner
ZW6189A1 (en) *	1988-05-09	1990-05-09	Smithkline Beckman Corp	Anti-aggregatory peptides
FR2634207B1 (fr) *	1988-07-12	1990-09-07	Synthelabo	Derives de ((piperidinyl-4)methyl) benzazepines, leur preparation et leur application en therapeutique
US5039805A (en) *	1988-12-08	1991-08-13	Hoffmann-La Roche Inc.	Novel benzoic and phenylacetic acid derivatives
US5084466A (en) *	1989-01-31	1992-01-28	Hoffmann-La Roche Inc.	Novel carboxamide pyridine compounds which have useful pharmaceutical utility
DK0389189T3 (da) *	1989-03-23	1994-06-20	Pfizer	Diazepin antiallergimidler
JPH04211071A (ja) *	1990-03-05	1992-08-03	Hokuriku Seiyaku Co Ltd	多環式化合物
IL99537A (en) *	1990-09-27	1995-11-27	Merck & Co Inc	Fibrinogen receptor antagonists and pharmaceutical preparations containing them
IL99539A0 (en) *	1990-09-27	1992-08-18	Merck & Co Inc	Fibrinogen receptor antagonists and pharmaceutical compositions containing them
NZ239876A (en) *	1990-09-27	1993-12-23	Merck & Co Inc	Glycyl-b-alanine derivatives and pharmaceutical compositions thereof.
NZ239846A (en) *	1990-09-27	1994-11-25	Merck & Co Inc	Sulphonamide derivatives and pharmaceutical compositions thereof
WO1992007568A1 (en) *	1990-11-01	1992-05-14	Smithkline Beecham Corporation	η-TURN PEPTIDOMIMETICS AS FIBRINOGEN ANTAGONISTS
US5438118A (en) *	1990-11-30	1995-08-01	Smithkline Beechman Corp.	HIV protease inhibitors
US5321034A (en) *	1991-05-07	1994-06-14	Merck & Co., Inc.	Fibrinogen receptor antagonists
CA2071181A1 (en) *	1991-06-14	1992-12-15	Roger M. Freidinger	Benzodiazepine analogs
EP0593603B1 (en) *	1991-06-28	2002-11-20	Smithkline Beecham Corporation	Bicyclic fibrinogen antagonists
US5250679A (en) *	1991-10-18	1993-10-05	Genentech, Inc.	Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
US5674863A (en) *	1991-10-18	1997-10-07	Genentech, Inc.	Nonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptor
US5149699A (en) *	1991-10-24	1992-09-22	American Home Products Corporation	Substituted pyridopyrimidines useful as antgiotensin II antagonists
US5241065A (en) *	1992-02-25	1993-08-31	Schering Corporation	2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity
ES2113081T3 (es) *	1992-11-09	1998-04-16	Knoll Ag	1,4-benzotiazepinas utiles como agentes neurologicos.
NZ259802A (en) *	1992-12-21	1997-10-24	Smithkline Beecham Corp	Bicyclic derivatives and pharmaceutical compositions
US5493020A (en) *	1993-07-29	1996-02-20	Genentech, Inc.	Tricyclic inhibitors of the GPIIb IIIa receptor
ZA955391B (en) *	1994-06-29	1996-02-09	Smithkline Beecham Corp	Vitronectin receptor antagonists

1995
- 1995-01-02 MA MA23747A patent/MA23420A1/fr unknown
- 1995-01-04 IL IL11224395A patent/IL112243A/xx not_active IP Right Cessation
- 1995-01-05 ZA ZA9545A patent/ZA9545B/xx unknown
- 1995-01-06 AP APAP/P/1995/000710A patent/AP542A/en active
- 1995-01-09 EP EP95908006A patent/EP0738150B1/en not_active Expired - Lifetime
- 1995-01-09 JP JP7518646A patent/JPH09508620A/ja not_active Ceased
- 1995-01-09 DK DK95908006T patent/DK0738150T3/da active
- 1995-01-09 US US08/875,359 patent/US6117866A/en not_active Expired - Fee Related
- 1995-01-09 AT AT95908006T patent/ATE238993T1/de not_active IP Right Cessation
- 1995-01-09 BR BR9506499A patent/BR9506499A/pt not_active Application Discontinuation
- 1995-01-09 DE DE69530571T patent/DE69530571T2/de not_active Expired - Fee Related
- 1995-01-09 CN CN95191991A patent/CN1117569C/zh not_active Expired - Fee Related
- 1995-01-09 ES ES95908006T patent/ES2197914T3/es not_active Expired - Lifetime
- 1995-01-09 CZ CZ19961981A patent/CZ292323B6/cs not_active IP Right Cessation
- 1995-01-09 KR KR1019960703660A patent/KR100388772B1/ko not_active IP Right Cessation
- 1995-01-09 PT PT95908006T patent/PT738150E/pt unknown
- 1995-01-09 AU AU16001/95A patent/AU699186B2/en not_active Ceased
- 1995-01-09 HU HU9601849A patent/HUT76282A/hu unknown
- 1995-01-09 NZ NZ279394A patent/NZ279394A/en not_active IP Right Cessation
- 1995-01-09 SG SG1996004249A patent/SG64884A1/en unknown
- 1995-01-09 WO PCT/US1995/000248 patent/WO1995018619A1/en active IP Right Grant
- 1995-01-09 SK SK869-96A patent/SK86996A3/sk unknown
- 1995-02-16 TW TW084101430A patent/TW420682B/zh not_active IP Right Cessation
1996
- 1996-07-05 BG BG100698A patent/BG62844B1/bg unknown
- 1996-07-05 NO NO962859A patent/NO962859L/no unknown
- 1996-07-05 OA OA60858A patent/OA10368A/en unknown
1998
- 1998-10-22 BG BG102863A patent/BG102863A/xx unknown
- 1998-12-28 HK HK98116053A patent/HK1014668A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
BG100698A (bg)	1997-02-28
NO962859D0 (no)	1996-07-05
BR9506499A (pt)	1997-09-09
AP9500710A0 (en)	1995-01-31
CZ292323B6 (cs)	2003-09-17
JPH09508620A (ja)	1997-09-02
SG64884A1 (en)	1999-05-25
ZA9545B (en)	1996-01-23
HU9601849D0 (en)	1996-09-30
BG62844B1 (bg)	2000-09-29
NO962859L (no)	1996-09-05
DE69530571D1 (de)	2003-06-05
KR100388772B1 (ko)	2003-11-20
CZ198196A3 (en)	1997-06-11
IL112243A0 (en)	1995-03-30
CN1143323A (zh)	1997-02-19
NZ279394A (en)	1998-05-27
WO1995018619A1 (en)	1995-07-13
BG102863A (en)	1999-05-31
EP0738150A1 (en)	1996-10-23
ES2197914T3 (es)	2004-01-16
AU1600195A (en)	1995-08-01
EP0738150A4 (en)	1997-03-19
AP542A (en)	1996-10-01
DK0738150T3 (da)	2003-08-25
AU699186B2 (en)	1998-11-26
SK86996A3 (en)	1997-02-05
CN1117569C (zh)	2003-08-13
US6117866A (en)	2000-09-12
MA23420A1 (fr)	1995-10-01
WO1995018619A9 (en)	2004-10-21
HK1014668A1 (en)	1999-09-30
IL112243A (en)	1999-12-31
EP0738150B1 (en)	2003-05-02
HUT76282A (en)	1997-07-28
DE69530571T2 (de)	2004-03-04
TW420682B (en)	2001-02-01
OA10368A (en)	2001-11-15
ATE238993T1 (de)	2003-05-15

Publication	Publication Date	Title
PT738150E (pt)	2003-08-29	Antagonistas biciclicos de fibrinogenio
DE69719354D1 (de)	2003-04-03	Muscarin-antagonisten
FI951135A0 (fi)	1995-03-10	Beetalaktaameja
DE69508690D1 (de)	1999-05-06	Motorrad
DE69828534D1 (de)	2005-02-10	Fahrradrad
DE69601904D1 (de)	1999-05-06	Rollerartiges Motorrad
ITMO960134A0 (it)	1996-10-17	Monopattino
DE59503420D1 (de)	1998-10-08	Schutzblechanordnung
IT1297359B1 (it)	1999-09-01	Motocicletta
DE69721159D1 (de)	2003-05-28	Fender
DE59501379D1 (de)	1998-03-05	Rollschuh
DE69711255D1 (de)	2002-05-02	Motorrad
BR9509559A (pt)	1997-09-16	Azolilulsolfonilfeniluracilas substituídas
DE69806489D1 (de)	2002-08-14	Fahrrad
FI942650A0 (fi)	1994-06-06	Lokasuoja
DE69712576D1 (de)	2002-06-20	Lastträger
KR960001540U (ko)	1996-01-19	자전거
DE59510274D1 (de)	2002-08-14	Substituierte biphenyloxazoline
BR9510060A (pt)	1998-06-02	Receptor
NO943423D0 (no)	1994-09-15	Sykkel
NO941227D0 (no)	1994-04-06	Sykkel
KR960017374U (ko)	1996-06-17	자전거
KR950027342U (ko)	1995-10-18	자전거용 휀다
BR9403250A (pt)	1996-09-03	Bicicleta
KR950024899U (ko)	1995-09-15	자전거용 발전장치